tirzepatide google scholar and Obesity: A Narrative Review : Advances in Human Biology Comparative safety and side effects

Here, we catch you up on the science and what it may mean for you

We recently encountered a similar case at our institution - a 49-year-old woman with type 2 diabetes, obesity, and chronic pain on long-term narcotic therapy, who presented with abdominal distension and vomiting after two years of tirzepatide (Mounjaro) therapy

Inspect visually for particulate matter or discoloration prior to use

Phentermine combined with alcohol can increase cardiovascular strain

Gastrointestinal effects may be compounded

Adults Wegovy is approved for adults who have: Obesity: BMI of 30 kg/m or greater, OR Overweight with complications: BMI of 27-30 kg/m with weight-related health problems Heart disease risk reduction: Adults with existing heart disease (without diabetes) and BMI 27 kg/m How is Wegovy Administered